Evaluation of the Effectiveness of N-acetylcysteine on Accelerating the Recovery of Renal Failure in Patients with Leptospirosis, a Randomized Clinical Trial Study

Overview

Journal Ann Med Surg (Lond)

Publisher Wolters Kluwer

Specialty Medical Education

Date 2021 Jul 14

PMID 34257959

Authors

Lotfollah Davoodi

Narjes Roudsar Ebrahimi

Hamideh Izadyar

Siavash Moradi

Alireza Razavi

Zakaria Zakariaei

Eissa Soleymani

Affiliations

Soon will be listed here.

Abstract

Background: Limited studies have been conducted on patients with renal function recovery regarding severe leptospirosis. The purpose of this study is to evaluate the effectiveness of N-acetylcysteine (NAC) in accelerating the reduction of serum creatinine in patients with leptospirosis.

Patients And Methods: This is a clinical trial study involving 64 patients with leptospirosis, with microscopic agglutination tests used to confirm the diagnosis of acute kidney injury. NAC was given to patients with a glomerular filtration rate of less than 60 ml/min at 1200 mg every 12 h, and it lasted for 48 h. Next, 32 patients were measured and the relationship between the length of hospitalization, age, and sex was also examined. Additionally, the two groups of case and control were compared in terms of the rate of decrease in serum creatinine level in three different time periods. The Shapro-Wilk test was used to investigate the distribution of data.

Results: No significant differences were observed in the decrease in serum creatinine level on the first, third, and seventh days of hospitalization and also in the use of NAC between the case and control groups (P = 0.255). In addition, the use of NAC had no significant effect on reducing the length of hospitalization (P = 0.067).

Conclusion: Recovery of acute kidney injury following leptospirosis and drugs that accelerate the healing process in these patients require further studies with greater sample size and longer follow-up time.

References

Liamis G, Rizos E, Elisaf M . Reversible proximal tubular dysfunction in a patient with acute febrile illness and normal renal function: an evidence towards leptospirosis. Clin Nephrol. 2000; 53(4):316. View

Davila de Arriaga A, Rocha A, Yasuda P, De Brito T . Morpho-functional patterns of kidney injury in the experimental leptospirosis of the guinea-pig (L. icterohaemorrhagiae). J Pathol. 1982; 138(2):145-61. DOI: 10.1002/path.1711380205. View

Abdulkader R . Acute renal failure in leptospirosis. Ren Fail. 1997; 19(2):191-8. DOI: 10.3109/08860229709026275. View

Ko A, Galvao Reis M, Ribeiro Dourado C, Johnson Jr W, Riley L . Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet. 1999; 354(9181):820-5. DOI: 10.1016/s0140-6736(99)80012-9. View

Subramaniam R, Suarez-Cuervo C, Wilson R, Turban S, Zhang A, Sherrod C . Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Ann Intern Med. 2016; 164(6):406-16. DOI: 10.7326/M15-1456. View

Cengiz K, Sahan C, Sunbul M, Leblebicioglu H, Cuner E . Acute renal failure in leptospirosis in the black-sea region in Turkey. Int Urol Nephrol. 2002; 33(1):133-6. DOI: 10.1023/a:1014494012062. View

Marotto P, Nascimento C, Eluf-Neto J, Marotto M, Andrade L, Sztajnbok J . Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis. 1999; 29(6):1561-3. DOI: 10.1086/313501. View

Dupont H, Perie J, Jarrige B, Daijardin J . Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis. 1997; 25(3):720-4. DOI: 10.1086/513767. View

Daher E, Zanetta D, Abdulkader R . Pattern of renal function recovery after leptospirosis acute renal failure. Nephron Clin Pract. 2004; 98(1):c8-14. DOI: 10.1159/000079922. View

10.

Edwards C, Nicholson G, Hassell T, Everard C, Callender J . Leptospirosis in Barbados. A clinical study. West Indian Med J. 1990; 39(1):27-34. View

11.

Daher E, Zanetta D, Cavalcante M, Abdulkader R . Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg. 1999; 61(4):630-4. DOI: 10.4269/ajtmh.1999.61.630. View

12.

Nicholson G, Edwards C, Hassell T, Everard C, Callender J . Urinary diagnostic indices in the management of leptospirosis. Selection of patients for dialysis therapy. West Indian Med J. 1989; 38(1):33-8. View

13.

Ooi B, Chen B, Tan K, KHOO O . Human renal leptospirosis. Am J Trop Med Hyg. 1972; 21(3):336-41. DOI: 10.4269/ajtmh.1972.21.336. View

14.

Davoodi L, Razavi A, Jafarpour H, Heshmati M, Soleymani E, Ghasemian R . Relationship Between the Prevalence of Blood Groups and Severity of Leptospirosis: A Case-Control Study. Infect Dis (Auckl). 2020; 13:1178633720936273. PMC: 7318813. DOI: 10.1177/1178633720936273. View

15.

Berman S, Tsai C, Holmes K, FRESH J, WATTEN R . Sporadic anicteric leptospirosis in South Vietnam. A study in 150 patients. Ann Intern Med. 1973; 79(2):167-73. DOI: 10.7326/0003-4819-79-2-167. View

16.

Johnson Jr W, Silva I, Rocha H . Serum creatine phosphokinase in leptospirosis. JAMA. 1975; 233(9):981-2. View

17.

Covic A, Goldsmith D, Gusbeth-Tatomir P, Seica A, Covic M . A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. Nephrol Dial Transplant. 2003; 18(6):1128-34. DOI: 10.1093/ndt/gfg095. View

18.

Stern E, Galloway R, Shadomy S, Wannemuehler K, Atrubin D, Blackmore C . Outbreak of leptospirosis among Adventure Race participants in Florida, 2005. Clin Infect Dis. 2010; 50(6):843-9. DOI: 10.1086/650578. View

19.

. Section 4: Contrast-induced AKI. Kidney Int Suppl (2011). 2014; 2(1):69-88. PMC: 4089629. DOI: 10.1038/kisup.2011.34. View

20.

Sandilands E, Cameron S, Paterson F, Donaldson S, Briody L, Crowe J . Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol. BMC Clin Pharmacol. 2012; 12:3. PMC: 3293780. DOI: 10.1186/1472-6904-12-3. View